Chinese health biotech and the billion-patient market

Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized users.

Detalles Bibliográficos
Autores principales: Frew, Sarah E, Sammut, Stephen M, Shore, Alysha F, Ramjist, Joshua K, Al-Bader, Sara, Rezaie, Rahim, Daar, Abdallah S, Singer, Peter A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096943/
https://www.ncbi.nlm.nih.gov/pubmed/18183014
http://dx.doi.org/10.1038/nbt0108-37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096943/
https://www.ncbi.nlm.nih.gov/pubmed/18183014
http://dx.doi.org/10.1038/nbt0108-37

Ejemplares similares